Page 23 - பொது வரையறுக்கப்பட்டவை நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Share this article Share this article ResearchAndMarkets.com s offering. The Neurovascular Intervention Devices global market is expected to grow at a high single digit CAGR to reach $4,167.4 million by 2027. Over the decade, due to the technological advancements with emerging and innovative technologies used under minimally invasive conditions has led to the rapid development of neurovascular interventions. As a result of rapid advances, there is the great expansion in the potential therapeutic application for neurovascular diseases. Neurovascular Interventional devices are used to treat intracranial aneurysm, ischemic stroke, arteriovenous malformation, carotid stenosis and other diseases like intracranial stenosis, dural fistula. The market is primarily driven by the increase in incidence and prevalence of neurovascular diseases like intracranial aneurysm, stroke and arteriovenous malformations, increase in the aging population, technological advancement, acquisitions and fa

United statesDeutschland verwaltungs gmbLaura woodCerus endovascularJohnson cerenovusMedtronic public limited companyKaneka pharma americaCeretrieve ltd israelArtio medical incPorters five force analysisStryker corporationTherapeutics incMonarch biosciences incCerevasc incCardinal health incOffice hours call